These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25800034)

  • 1. Structural chromosomal aberrations as potential risk markers in incident cancer patients.
    Vodenkova S; Polivkova Z; Musak L; Smerhovsky Z; Zoubkova H; Sytarova S; Kavcova E; Halasova E; Vodickova L; Jiraskova K; Svoboda M; Ambrus M; Hemminki K; Vodicka P
    Mutagenesis; 2015 Jul; 30(4):557-63. PubMed ID: 25800034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal damage in peripheral blood lymphocytes of newly diagnosed cancer patients and healthy controls.
    Vodicka P; Polivkova Z; Sytarova S; Demova H; Kucerova M; Vodickova L; Polakova V; Naccarati A; Smerhovsky Z; Ambrus M; Cerna M; Hemminki K
    Carcinogenesis; 2010 Jul; 31(7):1238-41. PubMed ID: 20215138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome aberrations in peripheral blood lymphocytes of lung cancer patients exposed to radon and air pollution.
    Minina VI; Sinitsky MY; Druzhinin VG; Fucic A; Bakanova ML; Ryzhkova AV; Savchenko YA; Timofeeva AA; Titov RA; Voronina EN; Volobaev VP; Titov VA
    Eur J Cancer Prev; 2018 Jan; 27(1):6-12. PubMed ID: 27232209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health.
    Bonassi S; Hagmar L; Strömberg U; Montagud AH; Tinnerberg H; Forni A; Heikkilä P; Wanders S; Wilhardt P; Hansteen IL; Knudsen LE; Norppa H
    Cancer Res; 2000 Mar; 60(6):1619-25. PubMed ID: 10749131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin-induced chromosomal damage and shortening of telomeres in peripheral blood lymphocytes of incident cancer patients.
    Kroupa M; Polivkova Z; Rachakonda S; Schneiderova M; Vodenkova S; Buchler T; Jiraskova K; Urbanova M; Vodickova L; Hemminki K; Kumar R; Vodicka P
    Genes Chromosomes Cancer; 2018 Feb; 57(2):61-69. PubMed ID: 29052312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal damage and telomere length in peripheral blood lymphocytes of cancer patients.
    Vodenkova S; Kroupa M; Polivkova Z; Musak L; Ambrus M; Schneiderova M; Kozevnikovova R; Vodickova L; Rachakonda S; Hemminki K; Kumar R; Vodicka P
    Oncol Rep; 2020 Nov; 44(5):2219-2230. PubMed ID: 33000239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts.
    Hagmar L; Strömberg U; Bonassi S; Hansteen IL; Knudsen LE; Lindholm C; Norppa H
    Cancer Res; 2004 Mar; 64(6):2258-63. PubMed ID: 15026371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of DNA repair gene variants modulate chromosomal aberrations in healthy subjects.
    Vodicka P; Musak L; Frank C; Kazimirova A; Vymetalkova V; Barancokova M; Smolkova B; Dzupinkova Z; Jiraskova K; Vodenkova S; Kroupa M; Osina O; Naccarati A; Palitti F; Försti A; Dusinska M; Vodickova L; Hemminki K
    Carcinogenesis; 2015 Nov; 36(11):1299-306. PubMed ID: 26354780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients.
    Svoboda M; Slyskova J; Schneiderova M; Makovicky P; Bielik L; Levy M; Lipska L; Hemmelova B; Kala Z; Protivankova M; Vycital O; Liska V; Schwarzova L; Vodickova L; Vodicka P
    Carcinogenesis; 2014 Jul; 35(7):1510-5. PubMed ID: 24583926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
    Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
    Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
    Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
    Zhou Y; Wang Y; Ju X; Lan J; Zou H; Li S; Qi Y; Jia W; Hu J; Liang W; Zhang W; Pang L; Li F
    Biomark Med; 2015; 9(8):777-90. PubMed ID: 26230297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer.
    Sheu CC; Yu YP; Tsai JR; Chang MY; Lin SR; Hwang JJ; Chong IW
    Int J Cancer; 2006 Sep; 119(6):1419-26. PubMed ID: 16642481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
    Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area.
    Liou SH; Lung JC; Chen YH; Yang T; Hsieh LL; Chen CJ; Wu TN
    Cancer Res; 1999 Apr; 59(7):1481-4. PubMed ID: 10197617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrations Involving Chromosome 1 as a Possible Predictor of Odds Ratio for Colon Cancer--Results from the Krakow Case-Control Study.
    Galas A; Miszczyk J
    PLoS One; 2016; 11(1):e0147658. PubMed ID: 26824604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of chromosome aberrations in predicting breast cancer risk.
    Kolusayin Ozar MO; Orta T
    J Exp Clin Cancer Res; 2005 Jun; 24(2):217-22. PubMed ID: 16110754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
    Hofmann G; Balic M; Dandachi N; Resel M; Schippinger W; Regitnig P; Samonigg H; Bauernhofer T
    Clin Biochem; 2013 Oct; 46(15):1585-9. PubMed ID: 23792261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer.
    Dowling P; Clarke C; Hennessy K; Torralbo-Lopez B; Ballot J; Crown J; Kiernan I; O'Byrne KJ; Kennedy MJ; Lynch V; Clynes M
    Int J Cancer; 2012 Aug; 131(4):911-23. PubMed ID: 21953030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of MMP-9 for breast and non-small cell lung cancer patients' survival.
    Schveigert D; Cicenas S; Bruzas S; Samalavicius NE; Gudleviciene Z; Didziapetriene J
    Adv Med Sci; 2013; 58(1):73-82. PubMed ID: 23640949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.